Advertisement

A new alternative to an MRI?

By Mark Guarino, Crain's Chicago Business  |  April 25, 2016

Medical technology can spot disease, but often only when a patient already is in imminent danger. What if a simple handheld device could scan the body to detect disease much sooner?

Tee Green steps down as CEO of Greenway Health

By Michael Sandler  |  April 20, 2016

Greenway Health co-founder Tee Green is stepping down from the top office at the Carrollton, Ga.-based electronic health record and practice management company. He will stay on full time as executive chairman to focus on innovation and growth initiatives. Scott Zimmerman will replace him as CEO.

FDA reports a small risk of implant malfunction from medical scans

By Associated Press  |  April 01, 2016

Patients with pacemakers, drug pumps and other medical devices face a very small risk of electrical malfunction when undergoing medical scanning, but it shouldn't stop them from getting necessary care, according to health regulators.

Michigan Blues, Hygieia testing diabetes insulin delivery product

By Jay Greene, Crain's Detroit Business  |  March 31, 2016

Ann Arbor, Mich.-based Hygieia, a medical device company, has teamed up with Blue Cross and Blue Shield of Michigan to launch a demonstration project to help about 1,000 diabetic patients more effectively manage their disease.

Kellogg named president, CEO at Omron

Kellogg named president, CEO at Omron

By Katherine Davis, Crain's Chicago Business  |  March 31, 2016

Omron Healthcare, a $7 billion heart health technology manufacturer and distributor, named Ranndy Kellogg president and CEO, giving him responsibility for operations in the U.S. and Canada.

Genome sequencing rated top advance of past 40 years

Genome sequencing rated top advance of past 40 years

By Joseph Conn  |  March 26, 2016

The sequencing of the human genome—an achievement that capped a 13-year, $3 billion international effort funded by the federal government—represents the most significant breakthrough in healthcare over the past 40 years, according to Modern Healthcare readers.

FDA will review first-ever dissolving heart stent

By Associated Press  |  March 14, 2016

A disappearing medical implant will get a closer look from the Food and Drug Administration this week. The FDA meets on Tuesday to review Abbott Laboratories' first-of-a-kind heart stent that dissolves into the body after helping to clear fat-clogged arteries.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.